BCYC - Bicycle Therapeutics GAAP EPS of -$1.41 misses by $0.39 revenue of $11.4M misses by $1.52M
2023-08-03 13:56:13 ET
- Bicycle Therapeutics press release ( NASDAQ: BCYC ): Q2 GAAP EPS of -$1.41 misses by $0.39 .
- Revenue of $11.4M (+160.3% Y/Y) misses by $1.52M .
- Cash and cash equivalents were $340.4 million as of June 30, 2023, compared to $339.2 million as of December 31, 2022.
For further details see:
Bicycle Therapeutics GAAP EPS of -$1.41 misses by $0.39, revenue of $11.4M misses by $1.52M